0.000209316180140718 0.000241518669393107 0.00185164313201407 0.00172283317500433 0.0015296182394898 0.0015296182394898 0.0015296182394898 0.0015296182394898
Sign Up Today X
Thanks for submitting the form.
Stockreport

Trends in biopharma: the future of manufacturing [Yahoo! Finance]

Amgen Inc. (AMGN)  More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Demand for targeted therapies is rising, yet more efficient manufacturing processes are needed to support their delivery. The implementation of concepts such as process intensification and Industry 4.0 could play an important role in achieving this. Drawing on expert insights from Cytiva, Pharmaceutical Technology examines the market's key trends to evaluate how bioprocessing is set to evolve. The biopharma market is becoming increasingly competitive, and we can look to the rapid adoption of biosimilars as a key reason why. By nature of their lower clinical and R&D costs, biosimilar manufacturers are providing lower-cost alternatives to many of the industry's highest-revenue monoclonal antibody drugs, and the figures speak for themselves as to the damage their ongoing popularity will do to the biologics market. Data from Bernstein Research for the filgrastim category shows how biosimilar versions of Amgen's Neupogen achieved a market share of more than 70% in mid-2020, just five yea [Read more]
IMPACT SNAPSHOT EVENT TIME: AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AMGN alerts
from News Quantified
AMGN
NEWS
AMGN
Earnings
AMGN
Analyst Actions
AMGN
SEC Filings
Stockreport

Trends in biopharma: the future of manufacturing [Yahoo! Finance]

Amgen Inc.  (AMGN) 
More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Demand for targeted therapies is rising, yet more efficient manufacturing processes are needed to support their delivery. The implementation of concepts such as process intensification and Industry 4.0 could play an important role in achieving this. Drawing on expert insights from Cytiva, Pharmaceutical Technology examines the market's key trends to evaluate how bioprocessing is set to evolve. The biopharma market is becoming increasingly competitive, and we can look to the rapid adoption of biosimilars as a key reason why. By nature of their lower clinical and R&D costs, biosimilar manufacturers are providing lower-cost alternatives to many of the industry's highest-revenue monoclonal antibody drugs, and the figures speak for themselves as to the damage their ongoing popularity will do to the biologics market. Data from Bernstein Research for the filgrastim category shows how biosimilar versions of Amgen's Neupogen achieved a market share of more than 70% in mid-2020, just five yea [Read more]
IMPACT SNAPSHOT
EVENT TIME:
AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS